BIOPTEQ
ActiveSummary
BIOPTEQ has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €808,624 and a net result of €71,292. Equity has been growing by about 4% per year since 2018. Its solvency ranks better than 81% of 271 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 07-12-2005 Normal situation
- Activity
- Other research and development on natural sciences NACE 72109and 2 others
- Establishment unit
- 2.150.657.571 4550 Nandrin, since 27-12-2005
- Financial year end
- 31 December
- Peppol
- Reachable since 10-11-2025
Board and ownership
- MONSEUR ANNICKDirector · since 05-04-2017
- NEVEN PHILIPPEDirector
- SERTEYN DIDIERDirector
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €120,321
- ▲ 25.0%
- Turnover
- ≈ €310,000
- estimated
- Profit
- €71,292
- ▲ 32.9%
- Equity
- €808,624
- ▼ 0.9%
- Total assets
- €972,092
- ▲ 10.6%
- Employees on 31-12-2025
- 1
- =
Score breakdownlowers riskLiquidity: current ratio 5.58, cash €551,337Equity €808,624 (83.2% of total assets)Size: total assets €972,092Figures for financial year 2025 (filed on 17-06-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 83% of them on solvency, 86% on liquidity, 52% on profitability and 44% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 64 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as BIOPTEQ: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €625,000 and €980,000, founded between 2005 and 2011.
| Company | Total assets | Gross margin |
|---|---|---|
| BIOPTEQ Nandrin | €972,092 | €120,321 |
| DR. PEETERMANS ELS , OOGHEELKUNDE Pajottegem | €897,744 | €166,748 |
| DOKTER DENOLF HEIDI Tielt | €880,887 | €188,967 |
| Médecine générale VERHAEREN -GOFFARD Theux | €980,223 | €222,690 |
| SPIAPS Liège | €930,423 | €191,026 |
| Société Médicale Dr PARADA Trois-Ponts | €625,127 | €137,701 |
| Docteur Masson André-Marie - psychiatre Liège | €815,649 | €136,688 |
Key facts about BIOPTEQ
- What is the company number of BIOPTEQ?
- The company number of BIOPTEQ is 0877.753.196. The VAT number is the same number with BE in front: BE 0877.753.196.
- Where is BIOPTEQ based?
- The registered office is at Rue des Martyrs 47, 4550 Nandrin.Company details
- What does BIOPTEQ do?
- According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
- What is the legal form of BIOPTEQ?
- The legal form of BIOPTEQ is Private limited company (BV).
- When was BIOPTEQ founded?
- BIOPTEQ was founded on 07-12-2005.
- Is BIOPTEQ still active?
- Yes, BIOPTEQ is an active enterprise in the KBO register.
- How many employees does BIOPTEQ have?
- BIOPTEQ had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of BIOPTEQ?
- The turnover in financial year 2025 is ≈ €310,000. This figure is estimated from the gross margin of €120,321 and 1,647 comparable companies of the same size. It probably lies between €190,000 and €570,000. It is a rough estimate. In financial year 2022 turnover was €254,160.
- Is BIOPTEQ profitable?
- In financial year 2025, BIOPTEQ made a profit of €71,292.
- Where can I find the annual accounts of BIOPTEQ?
- BIOPTEQ filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BIOPTEQ due?
- BIOPTEQ must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.